Related Experiment Video
Updated: Dec 6, 2025

Spatio-Temporal Manipulation of Small GTPase Activity at Subcellular Level and on Timescale of Seconds in Living Cells
Published on: March 9, 2012
Synthetic lethality of RB1 and aurora A is driven by stathmin-mediated disruption of microtubule dynamics
Junfang Lyu1, Eun Ju Yang1, Baoyuan Zhang1
1Cancer Centre, Faculty of Health Sciences, University of Macau, Avenida da Universidade, Taipa, Macau, SAR, China.
Abstract:
RB1 mutational inactivation is a cancer driver in various types of cancer including lung cancer, making it an important target for therapeutic exploitation. We performed chemical and genetic vulnerability screens in RB1-isogenic lung cancer pair and herein report that aurora kinase A (AURKA) inhibition is synthetic lethal in RB1-deficient lung cancer. Mechanistically, RB1-/- cells show unbalanced microtubule dynamics through E2F-mediated upregulation of the microtubule destabilizer stathmin and are hypersensitive to agents targeting microtubule stability. Inhibition of AURKA activity activates stathmin function via reduced phosphorylation and facilitates microtubule destabilization in RB1-/- cells, heavily impacting the bipolar spindle formation and inducing mitotic cell death selectively in RB1-/- cells. This study shows that stathmin-mediated disruption of microtubule dynamics is critical to induce synthetic lethality in RB1-deficient cancer and suggests that upstream factors regulating microtubule dynamics, such as AURKA, can be potential therapeutic targets in RB1-deficient cancer.
Insights
Targeting aurora kinase A (AURKA) shows synthetic lethality in RB1-deficient lung cancer. AURKA inhibition disrupts microtubule dynamics, selectively killing cancer cells lacking RB1.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Genetics
Background:
- RB1 gene inactivation is a key driver in many cancers, including lung cancer.
- RB1 deficiency creates vulnerabilities exploitable for targeted cancer therapies.
Purpose of the Study:
- To identify therapeutic targets for RB1-deficient lung cancer.
- To investigate the mechanism of synthetic lethality in RB1-deficient cancer cells.
Main Methods:
- Chemical and genetic screening of RB1-isogenic lung cancer cell lines.
- Analysis of microtubule dynamics and spindle formation.
- Assessment of cell death induction upon AURKA inhibition.
Main Results:
- Aurora kinase A (AURKA) inhibition demonstrated synthetic lethality in RB1-deficient lung cancer cells.
- RB1 deficiency leads to microtubule instability via stathmin upregulation.
- AURKA inhibition enhances stathmin activity, causing mitotic catastrophe and selective cell death in RB1-/- cells.
Conclusions:
- Stathmin-mediated microtubule destabilization is crucial for synthetic lethality in RB1-deficient cancers.
- AURKA represents a potential therapeutic target for RB1-deficient lung cancers by modulating microtubule dynamics.
Related Concept Videos
Destabilization of Microtubules
Drugs that Destabilize Microtubules
Microtubule Instability
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
DNA Damage can Stall the Cell Cycle
Restarting Stalled Replication Forks

